Daiwa Securities Group
EVLO

Daiwa Securities Group’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Daiwa Securities Group’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7
Closed – – 1424
2023
Q3 		$0 Hold
7
– – ﹤0.01% 1363
2023
Q2 		$0 Sell
7
-1
-13% -$3 ﹤0.01% 1373
2023
Q1 		$0 Hold
8
– – ﹤0.01% 1333
2022
Q4 		$0 Hold
8
– – ﹤0.01% 1421
2022
Q3 		$0 Hold
8
– – ﹤0.01% 1428
2022
Q2 		$0 Hold
8
– – ﹤0.01% 1461
2022
Q1 		$1K Hold
8
– – ﹤0.01% 1363
2021
Q4 		$1K Buy
+8
New +$1.35K ﹤0.01% 1374

Other funds holding EVLO

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Daiwa Securities Group's EVLO Position: Q4 2023 in Review

Daiwa Securities Group sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q4 2023, closing a stake of 7 shares.

Daiwa Securities Group first reported a position in EVLO in Q4 2021 and held it in 8 quarters. The position peaked at $1K in Q1 2022. 2 funds tracked by Wall St. Rank hold EVLO as of Q4 2023.

  • Daiwa Securities Group reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Daiwa Securities Group sold 7 Evelo Biosciences, Inc. Common Stock shares in Q4 2023.
  • Daiwa Securities Group first reported a position in Evelo Biosciences, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • Daiwa Securities Group's Evelo Biosciences, Inc. Common Stock position peaked at $1K in Q1 2022.
  • 2 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q4 2023.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.